Bayer has completed its acquisition of Perfuse Therapeutics, Inc., a biopharmaceutical company focused on treatments for ischemia-induced ocular diseases, according ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE